The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 22, 2011

Filed:

Oct. 13, 2009
Applicants:

Joyce Taylor-papadimitriou, Berkhamsted Hertfordshire, GB;

Lukas Carl Heukamp, London, GB;

Rienk Offringa, Lieden, NL;

Cornelis Johanna Maria Melief, Haarlem, NL;

Bruce Acres, Straβbourg, FR;

Mireille Thomas, Straβbourg, FR;

Inventors:

Joyce Taylor-Papadimitriou, Berkhamsted Hertfordshire, GB;

Lukas Carl Heukamp, London, GB;

Rienk Offringa, Lieden, NL;

Cornelis Johanna Maria Melief, Haarlem, NL;

Bruce Acres, Straβbourg, FR;

Mireille Thomas, Straβbourg, FR;

Assignees:

Transgene S.A., Illkirch Graffenstaden, FR;

Imperial Cancer Research Technology. Ldt., London, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/08 (2006.01); C12N 5/02 (2006.01); C12N 5/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Described are peptides and polypeptides derived from the MUC-1 polypeptide which are able to activate Cytotoxic T Lymphocyte (CTL) response, analogues of such peptides and polypeptides nucleotide sequences encoding such peptides and polypeptides and therapeutic uses thereof. Moreover, indications for selecting appropriate minimal antigenic MUC-1 polypeptides with reference to the HLA-type of the patient to be treated or tested are described.


Find Patent Forward Citations

Loading…